Correlation between erythrocyte sedimentation rate and C-reactive protein level in patients with rheumatic diseases
Data nadesłania: 10-07-2015
Data akceptacji: 19-09-2015
Data publikacji online: 08-12-2015
Data publikacji: 31-10-2015
Reumatologia 2015;53(5):243-246
Objectives: Erythrocyte sedimentation rate (ESR) and serum level of C-reactive protein (CRP) are the acute phase reactants most commonly determined in patients with rheumatic diseases. The indices are affected by different factors, but both of them are applied for evaluation of the disease activity in patients with inflammatory disorders of the musculoskeletal system.
Material and methods: The authors compared the results of ESR and CRP, which were carried out during routine diagnosis in 200 patients admitted to the Department of Rheumatology.
Results: A significant correlation between ESR and CRP was found (ESR after 1 h/CRP: correlation coefficient 0.6944, ESR after 2 h/CRP: correlation coefficient 0.6126). There was no difference in ESR or CRP between male and female patients, and patients older than 40 years had higher ESR and CRP.
Conclusions: The obtained results support the usefulness of both indices in the clinical practice of rheumatologists.
Madrenas J, Potter P, Cairns E. Giving credit where credit is due: John Hunter and the discovery of erythrocyte sedimentation rate. Lancet 2005; 366: 2140-2141.
Kucharz EJ. Edmund Biernacki and the erythrocyte sedimentation rate. Lancet 1987; 329: 696.
Ablij H, Meinders A. C-reactive protein: history and revival. Eur J Intern Med 2002; 13: 412-422.
Kucharz EJ. Chronic inflammation-enhanced atherosclerosis: Can we consider it as a new clinical sysndrome? Med Hypo­theses 2012; 78: 396-397.
Bijsma JW. Optimal treatment of rheumatoid arthritis: EULAR recommendations for clinical practice. Pol Arch Med Wewn 2010; 120: 347-353.
de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, et al. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid A protein for patient selection and monitoring of anti-tumor necrosis treatment in ankylosing spondylitis. Arthritis Rheum 2009; 61: 1484-1490.
Ruof J, Stucki G. Validity aspects of erythrocyte sedimentation rate and C-reactive protein in ankylosing spondylitis: a literature review. J Rheumatol 1999; 26: 966-970.
Nordal EB, Zak M, Aalto K, et al. Validity and predictive ability of the juvenile arthritis disease disease activity score based on CRP versus ESR in a Nordic population – based setting. Ann Rheum Dis 2012; 71: 1122-1127.
Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, et al. C-reactive protein and complement components but not-other acute-phase reactions discriminate between clinical subsets and organ damage in systemic lupus erythematosus. Clin Lab 2011; 57: 607-613.
Hamdi W, Néji O, Ghannouchi MM, et al. Comparative study of indices of activity evaluation in rheumatoid arthritis. Ann Phys Rehabil Med 2011; 54: 421-428.
Silva I, Mateus M, Branco JC. Velocidade de sedimentação on proteina C reactiva. Que variaveis utilizar na avaliacao clinica dos doentes com artivite reumatóide? Acta Reumatol Port 2010; 25: 456-462.
Siemons L, ten Klooster PM, Vonkeman HE, et al. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskeletal Dis 2015; 15: 368-374.
Shearn MA, Kang IY. Effect of age and sex on the erythrocyte sedimentation rate. J Rheumatol 1986; 13: 297-298.
Lee YJ, Lee JH, Shin YH, et al. Gender difference and determination of C-reactive protein level in Korean adults. Clin Chem Lab Med 2009; 47: 863-869.
Piéroni L, Bastard JP, Piton A, et al. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab 2003; 29: 133-138.
Gafter-Gvili A, Leibovici L, Molad Y. Elevation of inflammatory markers in patients with systemic lupus erythematosus is associated with poorer outcome. Biomed Pharmacother 2013; 67: 48-52.
Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res Ther 2014; 16: R40.
Navarro-Compán V, Gherghe AM, Smolen JS, et al. Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature review. Rheumatology 2015; 54: 994-1007.
Chen CH, Chen HA, Liao HT, et al. The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient’s poor physical mobility. Rheumatol Int 2015; 35: 1263-1267.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Journals System - logo
Scroll to top